CD34 Selection Efficiency
Patient . | Cycle . | Before CD34 Selection . | After CD34 Selection . | ||
---|---|---|---|---|---|
. | . | TNC × 1010 . | % CD34 . | % CD34 . | % Recovery . |
1 | 1.7* | 5.6 | 92.2 | 89.2 | |
2 | 1.4* | 3.4 | 81.8 | 73.2 | |
3 | 1 | 1.0 | 2.5 | 81.9 | 64 |
2 | 2.6* | 1.2 | 83.3 | 38.8 | |
3 | 1.7 | 0.9 | 92.1 | 56.5 | |
4 | 2.5* | 4.3 | 70.7 | 85 | |
5 | 1 | 1.4 | 3.5 | 94.2 | 47.5 |
2 | 1.7 | 1.3 | 91.1 | 95 | |
6 | 1 | 1.04 | 3.03 | 88.2 | 67.7 |
2 | 1.2 | 2.6 | 89.8 | 95 | |
3 | 1.6 | 3.8 | 87.5 | 22 | |
7 | 3.1* | 2.8 | 82.6 | 95 | |
8 | 2.2* | 1.6 | 76.6 | 95 | |
9 | 2.5* | 2.1 | 68.8 | 29.5 | |
10 | 3.5* | 0.9 | 89.3 | 66.3 | |
11 | 1 | 1.3 | 2.6 | 82.2 | 30.9 |
2 | 1.2 | 1.4 | 89.3 | 81.1 | |
12 | 1 | 1.1 | 2.1 | 51.3 | 90 |
2 | 2.7* | 3.1 | 79 | 64 | |
13 | 1 | 1.1 | 1.1 | 45 | 80.8 |
2 | 0.88 | 6.3 | 65.1 | 30.7 | |
3 | 1.4 | 1.8 | 94.3 | 87.1 | |
4 | 1.3 | 0.4 | 95.4 | 92.7 | |
Median (range) | 1.4 (0.88-3.5) | 2.5 (0.4-6.3) | 83.3 (45-95.4) | 73.2 (22-95) | |
Mean | |||||
(±SD) | 1.7 (±0.7) | 2.5 (±1.5) | 81.4 (±13.4) | 69.0 (±24.6) |
Patient . | Cycle . | Before CD34 Selection . | After CD34 Selection . | ||
---|---|---|---|---|---|
. | . | TNC × 1010 . | % CD34 . | % CD34 . | % Recovery . |
1 | 1.7* | 5.6 | 92.2 | 89.2 | |
2 | 1.4* | 3.4 | 81.8 | 73.2 | |
3 | 1 | 1.0 | 2.5 | 81.9 | 64 |
2 | 2.6* | 1.2 | 83.3 | 38.8 | |
3 | 1.7 | 0.9 | 92.1 | 56.5 | |
4 | 2.5* | 4.3 | 70.7 | 85 | |
5 | 1 | 1.4 | 3.5 | 94.2 | 47.5 |
2 | 1.7 | 1.3 | 91.1 | 95 | |
6 | 1 | 1.04 | 3.03 | 88.2 | 67.7 |
2 | 1.2 | 2.6 | 89.8 | 95 | |
3 | 1.6 | 3.8 | 87.5 | 22 | |
7 | 3.1* | 2.8 | 82.6 | 95 | |
8 | 2.2* | 1.6 | 76.6 | 95 | |
9 | 2.5* | 2.1 | 68.8 | 29.5 | |
10 | 3.5* | 0.9 | 89.3 | 66.3 | |
11 | 1 | 1.3 | 2.6 | 82.2 | 30.9 |
2 | 1.2 | 1.4 | 89.3 | 81.1 | |
12 | 1 | 1.1 | 2.1 | 51.3 | 90 |
2 | 2.7* | 3.1 | 79 | 64 | |
13 | 1 | 1.1 | 1.1 | 45 | 80.8 |
2 | 0.88 | 6.3 | 65.1 | 30.7 | |
3 | 1.4 | 1.8 | 94.3 | 87.1 | |
4 | 1.3 | 0.4 | 95.4 | 92.7 | |
Median (range) | 1.4 (0.88-3.5) | 2.5 (0.4-6.3) | 83.3 (45-95.4) | 73.2 (22-95) | |
Mean | |||||
(±SD) | 1.7 (±0.7) | 2.5 (±1.5) | 81.4 (±13.4) | 69.0 (±24.6) |
Indicates that two leukapheresis products were pooled for this selection procedure.